Sirnaomics Ltd. announces that with effect from May 31, 2024 Dr. Francois Lebel has resigned from the position as the Chief Medical Officer of the Group to devote more time to his other commitments. Dr. Lebel has agreed to serve as a senior consultant for strategic drug development matters for the Group.